Cadence Design Systems, Inc. (CDNS)

Cadence Design Systems is trading near the middle of its 52-week range, and the question for investors is whether the stock can build on its recent earnings momentum. Shares sit at $329.26, just above the 20-day EMA of $328.33 and the 200-day SMA of $327.92, while the 50-day SMA of $319.93 lies below. The company has beaten EPS estimates in all seven of the recent reports tracked, yet the share price fell in the first session after two of them, so the beats have not reliably lifted the stock. Analysts remain strongly supportive, with 22 of 24 rating it Buy or Strong Buy, but at a trailing P/E of 62.24 the valuation is well above the sector median.

Cadence has beaten its EPS estimate in each of the last seven reports, the most recent being the October 26, 2026 report, where adjusted EPS of $2.11 topped the $2.05 estimate by 2.93%. The share price rose 6.49% in the first session after that report. The record is strong on the numbers, but the market reaction has been mixed: the share price fell in the first session after 2 of the 7 reports, including the April 27, 2026 report, where it dropped 3.34%. A beat has therefore been a necessary condition for good trading rather than a guarantee of it.

The trailing P/E of 62.24 is at a premium to peers and sits 77.3% above the sector median P/E of 35.1. Growth is expected to carry the stock into the valuation: analysts forecast EPS of $4.85 for this fiscal year, up 19.4%.

Cadence reports a net profit margin of 22.51%, an operating margin of 28.93% and a return on equity of 22.87%, against a sector median return on equity of 13.4%. Its debt-to-equity ratio is 0.41. The company pays no dividend, so returns depend entirely on the share price and on growth.

Insiders sold $116.8M of stock over the last 18 months across 51 sales, and made no open-market purchases in that period. Such sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases would be. Against that, analysts remain broadly positive. Rosenblatt, JP Morgan, Baird and Needham all kept their ratings on October 27, 2026, and 22 of the 24 analysts with a current rating rate the stock Buy or Strong Buy, with none at Sell.

Our base case over the coming months is that the stock keeps trading in a range around its moving averages while the company's earnings growth does the work. Analysts expect revenue to grow 21.0% and EPS to grow 19.4% this fiscal year, and that growth is what the median target of $420.00 depends on. The stock would look stronger if it holds above the 200-day and 50-day averages through a sustained rise in the share price and quarterly EPS keeps beating estimates as it has in every report on record. The lowest analyst target of $300.00 marks the bearish end of the analysts' range. Analyst targets are the analysts' forecasts, not CleaRank's, and they can prove wrong.

Support sits first at the 20-day EMA of $328.33, which the price is only just above, so a small drop would test it. The 200-day SMA at $327.92 sits just below it and forms a combined support zone. The 50-day SMA at $319.93 is the next floor if that zone gives way. The 52-week low of $262.75 is the deepest support on the chart. Resistance begins at the 52-week high of $416.69, the only level above the price, so a rally would first have to clear the wide gap up to that high.